Avoca, a division of New Jersey ingredient supplier Pharmachem Laboratories, has signed a deal to commercialize
astaxanthin with biotech company Synthetic Genomics Inc.
SGI will supply the biomass and… Continue reading Phamachem signs deal for vertically integrated, US-made astaxanthin
KEARNY, N.J. and LA JOLLA, Calif., June 20, 2014 /PRNewswire/ — Avoca, Inc., a division of Pharmachem Laboratories, Inc., has formed a supply agreement with Synthetic Genomics, Inc. (SGI), a privately held company developing and commercializing… Continue reading Avoca Signs Supply Agreement with Synthetic Genomics, Inc. to Become Domestic Source of Natural Astaxanthin
[Portugal] A consortium of biotechnology experts has started to build a one-hectare pilot unit for the production of microalgae in Portugal, according to Wageningen UR, Continue reading Algae cultivation, biodiesel project to be demoed in Portugal